SEC Tracker
Get the app

Lycia Therapeutics LYCA

Lycia Therapeutics amends corporate documents

Item 5.03 Amends charter or bylaws

Form
8-K
Filed
Importance
Routine
  1. Filed Amended and Restated Certificate of Incorporation with Delaware Secretary of State
  2. Amended and Restated Bylaws became effective post-IPO
  3. Exhibits 3.1 and 3.2 include the Charter and Bylaws

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Lycia Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX